Norwegian Chapter in the Chambers Life Sciences & Pharma IP Litigation 2025
10.02.2025
Lars Erik Steinkjer, Nora Bratheim and Guro S. Kyrkjebø Nybø have contributed to the Norwegian chapter in the Chambers and Partners Life Sciences & Pharma IP Litigation 2025 Global Practice Guide.
Lesetid 1 minutt
The Chambers and Partners Life Sciences & Pharma IP Litigation 2025 Global Practice Guide covers the latest developments in patent litigation, generic and biosimilar market entry, patent term extensions, available forms of relief, other IP rights, appeal, ADR and settlement/antitrust considerations.
Our commentary provides expert insights on life science and pharma intellectual property litigation in Norway, relevant for everyone working within these sectors or with IP litigation in general.
Forfattere